Contents
Mechanisms
5 CINV: pathophysiology
and mechanisms
Sandra Melville
Guidelines
13 Improving adherence and
clinical outcomes
Alex Molassiotis
Risk factors
25 Risk factors and incidence
of CINV
George Dranitsaris
Clinical burden
33 Clinical burden of CINV
Meinolf Karthaus
Pharmacoeconomics
43 Economic burden of CINV
Rosanna Tarricone
Treatment
51 Current status and future
considerations in treatment
Tiene Bauters
Drug–drug interactions
65 Drug-drug interactions of the
main antiemetic agents
Snežana Bošnjak and
Sandra Vezmar Kovacevic
Pharmacy
77 The role of the specialist
pharmacist
Carl Booth and Saul Parkinson
Made possible by a contribution from Helsinn Healthcare SA.
Helsinn did not have any influence on the content and all items
were subject to independent peer and editorial review
hospitalpharmacyeurope.com | 2018 | 3